A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma

Figure 2

Connexin-based consensus clustering analysis. (a) Consensus cluster analysis. (b)-(c) Relative change of CDF curve. (d) The Kaplan–Meier survival analysis. (e) Principal component analysis of the two clusters. (f) Heatmap of connexin-related cluster.

(a)

(b)

(c)

(d)

(e)

(f)